The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

All of a sudden we were just thrown into having to learn everything imaginable the same day that he needed to start shots,” ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Gut microbes in early life play a key role in shaping insulin production and diabetes risk, with Candida dubliniensis showing ...

At age 8, Elizabeth Bennett was sick for two weeks. She lost weight. She couldn’t get off the sofa by herself. She missed ...

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...